{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:02:54Z","timestamp":1778335374814,"version":"3.51.4"},"reference-count":53,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:p>Estrogen deficiency causes bone loss by increasing the number of bone-resorbing osteoclasts. Selective p38\u03b1 MAPK inhibitors prevent bone-wasting effects of estrogen withdrawal but implicated mechanisms remain to be identified. Here, we show that inactivation of the p38\u03b1-encoding gene in osteoblast lineage cells with the use of an osteocalcin-cre transgene protects mice from ovariectomy-induced bone loss (a murine model of postmenopausal osteoporosis). Ovariectomy fails to induce bone loss, increase bone resorption, and stimulate receptor activator of nuclear factor \u03baB ligand and IL-6 expression in mice lacking p38\u03b1 in osteoblasts and osteocytes. Finally, TNF\u03b1 or IL-1, which are osteoclastogenic cytokines overproduced in the bone marrow under estrogen deficiency, can activate p38\u03b1 signaling in osteoblasts, but those cytokines cannot enhance Rankl and Il6 expressions or increase osteoclast formation in p38a-deficient osteoblast cultures. These findings demonstrate that p38\u03b1 MAPK signaling in osteoblast lineage cells mediates ovariectomy-induced bone loss by up-regulating receptor activator of nuclear factor \u03baB ligand and IL-6 production.<\/jats:p>","DOI":"10.1210\/en.2015-1669","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T17:01:31Z","timestamp":1444150891000},"page":"4377-4387","source":"Crossref","is-referenced-by-count":17,"title":["Ablation of p38\u03b1 MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency"],"prefix":"10.1210","volume":"156","author":[{"given":"Cyril","family":"Thouverey","sequence":"first","affiliation":[{"name":"Service of Bone Diseases, Department of Internal Medicine Specialties, University Hospital of Geneva, 1205 Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Caverzasio","sequence":"first","affiliation":[{"name":"Service of Bone Diseases, Department of Internal Medicine Specialties, University Hospital of Geneva, 1205 Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"2020071612032816200_B1","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","article-title":"Cellular and molecular mechanisms of bone remodeling","volume":"285","author":"Raggatt","year":"2010","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr Rev"},{"key":"2020071612032816200_B3","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"2020071612032816200_B4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612032816200_B5","doi-asserted-by":"crossref","first-page":"28890","DOI":"10.1074\/jbc.271.46.28890","article-title":"Estrogen deficiency increases the ability of stromal cells to support osteoclastogenesis via an IL-1 and TNF mediated stimulation of M-CSF production","volume":"271","author":"Kimble","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1172\/JCI8672","article-title":"M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss","volume":"105","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612032816200_B7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-a","volume":"106","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071612032816200_B8","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1172\/JCI117606","article-title":"Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice","volume":"94","author":"Kitazawa","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071612032816200_B9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jbmr.5650100914","article-title":"Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6","volume":"10","author":"Miyaura","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2020071612032816200_B10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","article-title":"Increased osteoclast development after estrogen loss: mediation by interleukin-6","volume":"257","author":"Jilka","year":"1992","journal-title":"Science"},{"key":"2020071612032816200_B11","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI0215687","article-title":"Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency","volume":"110","author":"Weitzmann","year":"2002","journal-title":"J Clin Invest"},{"key":"2020071612032816200_B12","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/jbmr.2228","article-title":"Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-\u03b1 antibodies","volume":"29","author":"Tyagi","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2020071612032816200_B13","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1002\/art.27645","article-title":"Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice","volume":"62","author":"Djaafar","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2020071612032816200_B14","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","article-title":"Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-\u03ba B ligand (RANKL)-induced JNK activation","volume":"276","author":"Srivastava","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B15","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612032816200_B16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"2020071612032816200_B17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.cr.7290257","article-title":"Activation and signaling of the p38 MAP kinase pathway","volume":"15","author":"Zarubin","year":"2005","journal-title":"Cell Res"},{"key":"2020071612032816200_B18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","article-title":"Mechanisms and functions of p38 MAPK signaling","volume":"429","author":"Cuadrado","year":"2010","journal-title":"Biochem J"},{"key":"2020071612032816200_B19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2174\/156802609789630974","article-title":"The p38\u03b1 kinase plays a central role in inflammation","volume":"9","author":"Schieven","year":"2009","journal-title":"Curr Top Med Chem"},{"key":"2020071612032816200_B20","doi-asserted-by":"crossref","first-page":"23668","DOI":"10.1074\/jbc.272.38.23668","article-title":"Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase","volume":"272","author":"Wang","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B21","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI42285","article-title":"The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice","volume":"120","author":"Greenblatt","year":"2010","journal-title":"J Clin Invest"},{"key":"2020071612032816200_B22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1138\/20100480","article-title":"Discovering the multiple roles of the p38 pathway in bone biology","volume":"7","author":"Caverzasio","year":"2010","journal-title":"IBMS BoneKEy"},{"key":"2020071612032816200_B23","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1007\/s00018-012-0983-8","article-title":"The p38\u03b1 MAPK positively regulates osteoblast function and postnatal bone acquisition","volume":"69","author":"Thouverey","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"2020071612032816200_B24","doi-asserted-by":"crossref","first-page":"e102032","DOI":"10.1371\/journal.pone.0102032","article-title":"The p38\u03b1 MAPK function in osteoprecursors is required for bone formation and bone homeostasis in adult mice","volume":"9","author":"Rodr\u00edguez-Carballo","year":"2014","journal-title":"PLoS One"},{"key":"2020071612032816200_B25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-cellbio-101512-122347","article-title":"Mitogen-activated protein kinase pathways in osteoblasts","volume":"29","author":"Greenblatt","year":"2013","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2020071612032816200_B26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/bonekey.2015.80","article-title":"Focus on the p38 MAPK signaling pathway in bone development and maintenance","volume":"4","author":"Thouverey","year":"2015","journal-title":"Bonekey Rep"},{"key":"2020071612032816200_B27","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.4049\/jimmunol.0901026","article-title":"The \u03b1-isoform of p38 MAPK specifically regulates arthritic bone loss","volume":"183","author":"B\u00f6hm","year":"2009","journal-title":"J Immunol"},{"key":"2020071612032816200_B28","doi-asserted-by":"crossref","first-page":"31155","DOI":"10.1074\/jbc.M001229200","article-title":"Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-\u03ba B ligand (RANKL)","volume":"275","author":"Matsumoto","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B29","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/endo.143.8.8954","article-title":"p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function","volume":"143","author":"Li","year":"2002","journal-title":"Endocrinology"},{"key":"2020071612032816200_B30","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1074\/jbc.M111696200","article-title":"Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-\u03ba B ligand signaling","volume":"277","author":"Mansky","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1359\/jbmr.080410","article-title":"Prevention of trabecular bone loss induced by estrogen deficiency by a selective p38\u03b1 inhibitor","volume":"23","author":"Caverzasio","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2020071612032816200_B32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S8756-3282(00)00413-0","article-title":"The p38 mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor in osteoblasts","volume":"28","author":"Chae","year":"2001","journal-title":"Bone"},{"key":"2020071612032816200_B33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jcp.1082","article-title":"IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase","volume":"187","author":"Kumar","year":"2001","journal-title":"J Cell Physiol"},{"key":"2020071612032816200_B34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bone.2005.10.007","article-title":"TNF\u03b1 and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics","volume":"38","author":"Dai","year":"2006","journal-title":"Bone"},{"key":"2020071612032816200_B35","doi-asserted-by":"crossref","first-page":"44005","DOI":"10.1074\/jbc.M208265200","article-title":"Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization","volume":"277","author":"Zhang","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/embor.2008.149","article-title":"p38\u03b1 MAPK inhibits JNK activation and collaborates with I\u03baB kinase 2 to prevent endotoxin-induced liver failure","volume":"9","author":"Heinrichsdorff","year":"2008","journal-title":"EMBO Rep"},{"key":"2020071612032816200_B37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/jir.2006.26.719","article-title":"MKK3\/6-p38 MAPK signaling is required for IL-1\u03b2 and TNF-\u03b1-induced RANKL expression in bone marrow stromal cells","volume":"26","author":"Rossa","year":"2006","journal-title":"J Interferon Cytokine Res"},{"key":"2020071612032816200_B38","first-page":"17","article-title":"Regulation of TNF-\u03b1-induced IL-6 production in MG-63 human osteoblast-like cells","volume":"81","author":"Webb","year":"2002","journal-title":"J Dent Res"},{"key":"2020071612032816200_B39","doi-asserted-by":"crossref","first-page":"e84818","DOI":"10.1371\/journal.pone.0084818","article-title":"Differential roles of MAPK kinases MKK3 and MKK6 in osteoclastogenesis and bone loss","volume":"9","author":"Boyle","year":"2014","journal-title":"PLoS One"},{"key":"2020071612032816200_B40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4049\/jimmunol.178.1.192","article-title":"Osteoprotegerin reduces the serum level of receptor activator of NF-\u03baB ligand derived from osteoblasts","volume":"178","author":"Nakamichi","year":"2007","journal-title":"J Immunol"},{"key":"2020071612032816200_B41","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1210\/en.2003-1536","article-title":"Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-\u03baB ligand-mediated osteoclastogenesis","volume":"145","author":"Yoneda","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612032816200_B42","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI115668","article-title":"17 \u03b2-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens","volume":"89","author":"Girasole","year":"1992","journal-title":"J Clin Invest"},{"key":"2020071612032816200_B43","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1210\/endo.133.2.8393776","article-title":"Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal","volume":"133","author":"Passeri","year":"1993","journal-title":"Endocrinology"},{"key":"2020071612032816200_B44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2008.05.003","article-title":"Expression characteristic and significance of interleukin-6, nuclear factor \u03ba \u03b2, and bone formation markers in rat models of osteoporosis","volume":"152","author":"Zhu","year":"2008","journal-title":"Transl Res"},{"key":"2020071612032816200_B45","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/MCB.15.9.4971","article-title":"Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-\u03ba B and C\/EBP \u03b2","volume":"15","author":"Stein","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2020071612032816200_B46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1172\/JCI65910","article-title":"Estrogen receptor-\u03b1 signaling in osteoblast progenitors stimulates cortical bone accrual","volume":"123","author":"Almeida","year":"2013","journal-title":"J Clin Invest"},{"key":"2020071612032816200_B47","doi-asserted-by":"crossref","first-page":"36846","DOI":"10.1074\/jbc.M606656200","article-title":"Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-\u03baB ligand","volume":"281","author":"Hikita","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med"},{"key":"2020071612032816200_B49","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat Med"},{"key":"2020071612032816200_B50","doi-asserted-by":"crossref","first-page":"29851","DOI":"10.1074\/jbc.M112.377945","article-title":"Receptor activator of nuclear factor \u03baB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss","volume":"287","author":"Onal","year":"2012","journal-title":"J Biol Chem"},{"key":"2020071612032816200_B51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/jbmr.2096","article-title":"Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis","volume":"29","author":"Fumoto","year":"2014","journal-title":"J Bone Miner Res"},{"key":"2020071612032816200_B52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jbmr.5650060307","article-title":"Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype","volume":"6","author":"Kurihara","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2020071612032816200_B53","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.182.5.1461","article-title":"Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors","volume":"182","author":"Udagawa","year":"1995","journal-title":"J Exp Med"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/12\/4377\/8985681\/endo4377.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/12\/4377\/8985681\/endo4377.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T18:46:50Z","timestamp":1594925210000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/156\/12\/4377\/2422590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,6]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2015-1669","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,6]]}}}